K. Malekzadeh
Inova Fairfax Hospital(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, MicroRNA in disease regulation, Glioma Diagnosis and Treatment
Most-Cited Works
- → Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial(2013)89 cited
- → The role of miR-146a on NF-κB expression level in human umbilical vein endothelial cells under hyperglycemic condition(2016)32 cited
- → Phase I, safety, tolerability and preliminary efficacy study of tremelimumab (Trem) in combination with gefitinib (Gef) in EGFR-mutant (EGFR-mut) NSCLC (GEFTREM)(2016)14 cited
- → Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours(2017)11 cited
- Factors Affecting Early and Late Extubation in Liver Transplant Patients(2010)
- → Repair of bucket handle meniscus tears improves patient outcomes versus partial meniscectomy at the time of ACL reconstruction(2024)1 cited
- → 1523MO Initial active surveillance strategy for patients with peripheral sporadic desmoids: A multicentre phase II observational trial(2021)1 cited
- → Phase I Study of Tremelimumab (Trem) in Combination with Gefitinib (Gef) in Epidermal Growth Factor Receptor Mutant (Egfr-Mut) Non-Small Cell Lung Cancer (Nsclc)(2014)1 cited
- → 655MO A prospective phase II trial of cabazitaxel in male patients with chemotherapy pre-treated metastatic germ-cell tumors: The CABA-GCT study(2021)